Emily Bogen faced a critical juncture when her family recognized the need for intervention due to her ongoing battles with prescription drug addiction and neurological issues stemming from Lyme disease. Seeking a specialized treatment facility, she found a privately owned center on Vancouver Island run by Nomina Wellness through online research.
Expecting tailored care and top-notch services for a significant fee, the Bogen family’s experience at Nomina turned into a disappointment. The facility failed to deliver on promised treatment plans, one-on-one care, and luxury services. Moreover, the Vancouver Island location and another facility in Courtenay, B.C., faced distressing incidents, including a fatal overdose in October 2024.
This case underscores a broader issue in Canada: the lack of government oversight for for-profit private residential substance use treatment centers, posing risks to patients. An investigation by the fifth estate revealed a concerning trend where provincial authorities show minimal interest in regulating the privately owned recovery sector, leaving patients vulnerable without specific operational guidelines or mandated staff qualifications.
The absence of robust regulations also raises questions of accountability in incidents like the overdose death at Nomina in 2024. The lack of standardized training and certification requirements for addiction counselors allows unqualified individuals to practice, contributing to a concerning scenario where unscrupulous practices can thrive.
The story further unveils challenges in tracking patient outcomes and ensuring treatment quality. Former B.C. chief coroner Lisa Lapointe advocates for better oversight and data monitoring to address systemic failures in the private addiction treatment sector. However, responses from health ministers and facility owners suggest a reluctance to implement stringent regulations or acknowledge deficiencies in the current system.
As survivors like Emily Bogen continue to grapple with their experiences, the call for regulatory reforms in the private addiction treatment industry grows louder. The need for transparent standards, professional accountability, and patient-centered care remains paramount to safeguarding vulnerable individuals seeking recovery assistance.
